Location History:
- North Oaks, MN (US) (2018)
- Little Canada, MN (US) (2021)
Company Filing History:
3 out of 2,310 
2 out of 1,271 
2 out of 84 
Years Active: 2018-2025
Title: Jeff S. Miller: Innovator in Therapeutic Methods
Introduction
Jeff S. Miller, an accomplished inventor based in Little Canada, Minnesota, has made significant contributions to the field of medical therapeutics. With a total of three patents to his name, his work focuses primarily on therapeutic methods that enhance the treatment of severe conditions such as graft-versus-host disease and tumors.
Latest Patents
One of Jeff's latest patents, titled "Therapeutic methods involving modulating inflammasome activation of myeloid-derived suppressor cells," details innovative methods for treating subjects at risk of graft-versus-host disease (GvHD). This involves administering a specific plurality of myeloid-derived suppressor cells (MDSCs) that effectively alleviate symptoms associated with GvHD. Furthermore, Jeff has developed a method aimed at treating tumors, which includes co-administering an inflammasome inciting agent alongside anti-tumor therapy. This novel approach is designed to enhance the activation of MDSCs, thus reducing their suppressor function in the context of tumor treatment.
Career Highlights
Throughout his career, Jeff has been associated with reputable institutions like the University of Minnesota and the University of North Carolina at Chapel Hill. His work in these organizations has facilitated significant advancements in therapeutic methodologies, particularly in immunology and cancer treatment.
Collaborations
Jeff has collaborated with distinguished professionals in his field, including Bruce Robert Blazar and Brent Koehn. These partnerships have enriched his research endeavors and contributed to the successful development of his patented innovations.
Conclusion
In conclusion, Jeff S. Miller is a noteworthy inventor whose work has crucial implications for the treatment of serious medical conditions. His innovative therapeutic methods provide promising avenues for future research and treatment strategies, underscoring his role as a leader in the field of medical innovation.